Back
SpringWorks Therapeutics Vs. Alnylam Pharmaceuticals Industry Stock Comparison
Sell
22
SWTX
SpringWorks Therapeutics
Last Price:
38.69
Seasonality Move:
12.83%
Sell
15
ALNY
Alnylam Pharmaceuticals
Last Price:
246.59
Seasonality Move:
6.72%
Sell
22
SpringWorks Therapeutics (SWTX)
is a Sell
Is SpringWorks Therapeutics a Buy, Sell or Hold?
- The current SpringWorks Therapeutics [SWTX] share price is $38.70. The Score for SWTX is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
- SWTX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
15
Alnylam Pharmaceuticals (ALNY)
is a Sell
Is Alnylam Pharmaceuticals a Buy, Sell or Hold?
- The current Alnylam Pharmaceuticals [ALNY] share price is $246.78. The Score for ALNY is 15, which is 70% below its historic median score of 50, and infers higher risk than normal.
- ALNY is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
SWTX Stock Price Chart
What is SpringWorks Therapeutics's stock price today?
-
The SpringWorks Therapeutics share price today is $38.70
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SWTX is experiencing selling pressure, which indicates risk of future bearish movement.
ALNY Stock Price Chart
What is Alnylam Pharmaceuticals's stock price today?
-
The Alnylam Pharmaceuticals share price today is $246.78
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALNY is experiencing selling pressure, which indicates risk of future bearish movement.
SWTX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.86 | Buy |
Relative Strength Index (14 RSI): | 48.43 | Sell |
Chaikin Money Flow: | -246559 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (35.31 - 41.03) | Buy |
Bollinger Bands (100): | (36.62 - 43.22) | Sell |
ALNY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.98 | Buy |
Relative Strength Index (14 RSI): | 39.94 | Sell |
Chaikin Money Flow: | -378372 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (258.04 - 277.96) | Sell |
Bollinger Bands (100): | (152.5 - 260.08) | Buy |
SWTX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 40.65 | Sell |
20-day SMA: | 39.22 | Sell |
50-day SMA: | 38.12 | Buy |
200-day SMA: | 40.78 | Sell |
8-day EMA: | 40.17 | Sell |
20-day EMA: | 39.42 | Sell |
50-day EMA: | 38.9 | Sell |
200-day EMA: | 38.59 | Buy |
ALNY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 264.46 | Sell |
20-day SMA: | 268.49 | Sell |
50-day SMA: | 256.91 | Sell |
200-day SMA: | 187.09 | Buy |
8-day EMA: | 259.34 | Sell |
20-day EMA: | 263.1 | Sell |
50-day EMA: | 247.85 | Sell |
200-day EMA: | 202.56 | Buy |
SpringWorks Therapeutics Earnings Growth & SWTX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.45 per share, an increase next quarter of $0.57 per share, an increase this year of $1.06 per share, and an increase next year of $1.38 per share.
Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.57 per share, an increase next quarter of $0.47 per share, an increase this year of $1.30 per share, and an increase next year of $0.57 per share.
SpringWorks Therapeutics Technical Analysis
Aug 23 | Aug 26 | Aug 27 | Aug 28 | Aug 29 | Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | |
---|---|---|---|---|---|---|---|---|---|---|
Aug | Sep | |||||||||
23 | 26 | 27 | 28 | 29 | 30 | 03 | 04 | 05 | 06 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Alnylam Pharmaceuticals Technical Analysis
Aug 23 | Aug 26 | Aug 27 | Aug 28 | Aug 29 | Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | |
---|---|---|---|---|---|---|---|---|---|---|
Aug | Sep | |||||||||
23 | 26 | 27 | 28 | 29 | 30 | 03 | 04 | 05 | 06 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |